
Preprints with The Lancet is a collaboration between The Lancet Group of journals and SSRN to facilitate the open sharing of preprints for early engagement, community comment, and collaboration. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early-stage research papers that have not been peer-reviewed. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. The findings should not be used for clinical or public health decision-making or presented without highlighting these facts. For more information, please see the FAQs.
Seroprevalence of Pertussis in Chinese Population During 2010-2022: A Systematic Review and Meta-Analysis
25 Pages Posted: 29 Dec 2023
More...Abstract
Background: Pertussis is a vaccine-preventable infectious disease, however, data on pertussis antibody levels in a nationwide population are still limited in China. We aimed to pool seropositive rate of antibody against pertussis toxin (PT-IgG) among Chinese population.
Methods: We systematically searched PubMed, Web of Science, Embase, and China National Knowledge Infrastructure Database for studies published between 1 January 2010 and 30 June 2023. The studies reporting seroprevalence on PT-IgG among healthy Chinese population are included. Pooled estimates were obtained using random-effect meta-analyses. The age-specific estimates in different years were used meta-regression.
Findings: Thirty-nine studies involving 47 778 subjects reporting the seropositive rates of anti-PT IgG were included in the meta-analysis. The pooled seropositive rate in the whole population was 7.06% (95% CI, 5.50%-9.07%). In subgroup meta-analyses, the estimates were 8.71%, 12.50%, 8.15%, 8.96%, 8.90% ,6.36% and 8.96% for people y aged <1, 1-2, 3-4, 5-9, 10-19, 20-39, and ≥40 years, respectively. The highest estimate was 11.89% for subjects in East China, but the lowest estimate was 6.36% for those in Southwestern China. A trend of decreasing seropositive rate of anti-PT IgG was observed during the past eight years, with a relative decreasing rate of 56.82% to 58.50% from 2012 to 2020. In 2020, the seropositive rate ranged from 7.22% (95% CI, 4.62%-11.11%) among children younger than 1 year old to 5.99% (95% CI, 3.94%-9.02%) among adults aged 40 years and older.
Interpretation: This meta-analysis showed a low seropositive rate of anti-PT IgG in the Chinese population, especially in school-age children and young adult, highlighting the urgent need for great efforts to optimize the immunization strategy.
Funding: This work was supported by the Zhejiang Provincial Medical and Health Science and Technology Project (grant number 2024KY885).
Declaration of Interest: The authors declare no conflicts of interest.
Keywords: Pertussis, Antibodies, Pertussis toxin, China, Meta-analysis
Suggested Citation: Suggested Citation